CELGENE CORP /DE/ 4
4 · CELGENE CORP /DE/ · Filed Dec 31, 2013
Insider Transaction Report
Form 4
STEIN LAWRENCE V
See Remarks
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2013-12-27−1,271→ 40,000 totalExercise: $78.66Exp: 2022-12-03→ Common Stock (1,271 underlying) - Exercise/Conversion
Common Stock
2013-12-27$78.66/sh+1,271$99,977→ 1,321 total
Holdings
- 55(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]The option was fully exercisable.
- [F2]The option was issued pursuant to the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013).